Kenneth V Lawson

9PUBLICATIONS
9CO-AUTHORS
Molecular targetsChemical and thermal processes in energy and combustionCheminformatics and quantitative structure-activity relationshipsMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 05, 2026
Discovery of Casdatifan, Part II: A Potent and Orally Bioavailable Inhibitor of Hypoxia Inducible Factor-2α.

|Apr 29, 2026
Discovery of Casdatifan, Part I: Design and Characterization of Tetrahydroquinoline Inhibitors of Hypoxia-Inducible Factor-2α.

|Jan 13, 2025
Stereodivergent Synthesis of the Vicinal Difluorinated Tetralin of Casdatifan Enabled by Ru-Catalyzed Transfer Hydrogenation.

Guillaume Mata, Artur K Mailyan, Jeremy Fournier

|Oct 21, 2021
Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ).

Guillaume Mata, Dillon H Miles, Samuel L Drew

|Jan 05, 2021
Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors.

Ehesan U Sharif, Jaroslaw Kalisiak, Kenneth V Lawson

|Sep 01, 2020
Discovery of Potent and Selective PI3Kγ Inhibitors.

Samuel L Drew, Rhiannon Thomas-Tran, Joel W Beatty

Pageof 2

Frequent Collaborators

6 joint publications

Jenna L Jeffrey

5 joint publications

Guillaume Mata

4 joint publications

Brandon R Rosen

4 joint publications

Ehesan U Sharif